Dario A. Paggiarino is Chief Medical Officer of EyePoint Pharmaceuticals, Inc.. Currently has a direct ownership of 67,080 shares of EYPT, which is worth approximately $703,669. The most recent transaction as insider was on Feb 09, 2022, when has been sold 4,966 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 67.1K
0% 3M change
160.94% 12M change
Total Value Held $703,669

Dario A. Paggiarino Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 09 2022
BUY
Exercise of conversion of derivative security
-
4,966 Added 22.04%
17,561 Common Stock
Jun 14 2021
SELL
Payment of exercise price or tax liability
$4,053 $9.72 p/Share
417 Reduced 3.2%
12,595 Common Stock
Jun 14 2021
BUY
Exercise of conversion of derivative security
-
1,420 Added 9.84%
13,012 Common Stock
Feb 28 2021
SELL
Payment of exercise price or tax liability
$15,383 $10.81 p/Share
1,423 Reduced 10.93%
11,592 Common Stock
Feb 28 2021
BUY
Exercise of conversion of derivative security
-
4,105 Added 23.98%
13,015 Common Stock
DAP

Dario A. Paggiarino

Chief Medical Officer
Watertown, MA

Track Institutional and Insider Activities on EYPT

Follow EyePoint Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EYPT shares.

Notify only if

Insider Trading

Get notified when an Eye Point Pharmaceuticals, Inc. insider buys or sells EYPT shares.

Notify only if

News

Receive news related to EyePoint Pharmaceuticals, Inc.

Track Activities on EYPT